The use of CBD is safe, with a few non-serious potential side effects. This is shown by the studies and that is what doctors and scientists say. Most CBD users do not experience any of these side effects. Even in very high doses of CBD there is no toxicity. However, everyone is unique and the body chemistry of each individual is slightly different.
Most human studies of CBD have been done on people who have seizures, and the FDA recently approved the first CBD-based drug, Epidiolex, for rare forms of epilepsy. Clinical trials for other conditions are promising, but tiny. In one Brazilian study published in 2011 of people with generalized social anxiety disorder, for example, taking a 600-mg dose of CBD (higher than a typical dose from a tincture) lessened discomfort more than a placebo, but only a dozen people were given the pill.
The NCBI study does mention some potential side effects for cannabidiol, such as the inhibition of hepatic drug metabolism and decreased activity of p-glycoprotein. CBD can indeed interact with a series of pharmaceuticals, as it inhibits the activity of some liver enzymes called cytochrome P450. This family of enzymes metabolizes most of the pharmaceutical drugs used to treat humans.
Then there is the matter of which part of the plant is used. THC tends to be more concentrated in the leaves of the plant, while CBD in its stem and seeds. It should be noted that these aspects are relative. Some degree of agreement exists that for the purest CBD, the stalk of a hemp plant (varieties of cannabis generally grown for fiber manufacturing, low in THC), or much less often the seeds. Taking into account the fact that CBD supplements are usually in an oil form, one may fathom the origins of the nearly ubiquitous hemp oil dietary supplements.
Furthermore, this number is expected to grow. According to the CDC, it is estimated that by 2040, over 78 million adults will have arthritis that has been diagnosed by a doctor, with 43% of those individuals limited in terms of activity because of the disease, without taking into effect other conditions that contribute to arthritis side effects, like growing obesity numbers and more.
People who experience psychosis may produce too much or even too little cannabinoids (from overactive dopamine receptors). CBD is milder than our internal cannabinoids and helps to re-establish a balance of cannabinoids in the brain. CBD also helps lower inflammation, which is often increased in schizophrenia. THC, on the other hand, is stronger than our internal cannabinoids (anandamide and 2-AG), this way potentially triggering psychosis [46, 48].